﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>01</Month>
        <DAY>19</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Resolvin D1 alleviates lipopolysaccharide-induced in vitro corneal inflammation by modulating macrophage polarization through upregulation of c-Fos expression</ArticleTitle>
    <FirstPage>32639</FirstPage>
    <LastPage>32639</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.32639</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Qin</FirstName>
        <LastName>Qin</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1176-1601</Identifier>
      </Author>
      <Author>
        <FirstName>Yinru</FirstName>
        <LastName>Wang</LastName>
      </Author>
      <Author>
        <FirstName>Yajun</FirstName>
        <LastName>Liu</LastName>
      </Author>
      <Author>
        <FirstName>Weiwei</FirstName>
        <LastName>An</LastName>
      </Author>
      <Author>
        <FirstName>Zifang</FirstName>
        <LastName>He</LastName>
      </Author>
      <Author>
        <FirstName>Feifei</FirstName>
        <LastName>Chen</LastName>
      </Author>
      <Author>
        <FirstName>Xinxuan</FirstName>
        <LastName>Cheng</LastName>
      </Author>
      <Author>
        <FirstName>Deyan</FirstName>
        <LastName>Chen</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7351-4617</Identifier>
      </Author>
      <Author>
        <FirstName>Zhenggao</FirstName>
        <LastName>Xie</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2587-157X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.32639</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Bacterial keratitis refers to a prevalent sight-threatening ophthalmologic infection. Owing to the challenge of antimicrobial resistance in treating bacterial keratitis, novel therapeutic strategies are needed. Resolvin D1 (RvD1), an endogenous lipid mediator, exhibits anti-inflammatory and immune-regulatory effects. The present study was aimed at investigating whether RvD1 alleviates lipopolysaccharide-induced inflammation to protect corneal fibroblasts and explore its potential mechanisms.  Methods: In this study, Raw264.7 cells were polarized towards M1 or M2 macrophages by the addition of lipopolysaccharides LPS or interleukin (IL)-4, respectively, and were treated with or without RvD1. Flow cytometry and Western blot were used to determine the expression of M1 and M2-related markers. EdU assay and trans-well assay were performed to detect the proliferation and migration ability of corneal fibroblasts. Bioinformatics analysis (GO and KEGG) of RNA-seq was applied to explore the RvD1-related signaling pathways. siRNA-c-Fos was further used to confirm the role of Fos expression in RvD1-mediated macrophage polarization. Flow cytometry and Western blotting analysis were performed to demonstrate that RvD1 alleviated LPS-induced inflammation by suppressing M1 macrophage polarization, facilitating M2 macrophage polarization, and increasing corneal fibroblast proliferation. Bioinformatics analysis identified PI3K-AKT, IL-17, and MAPK signaling pathways as potential targets of RvD1 in corneal inflammation.  Results: Enrichment analysis indicated that the RvD1 target gene showed a strong relationship to the regulation of macrophage polarization. RvD1 highly upregulated M2 macrophages by promoting c-Fos expression and enhanced the proliferation and migration of mouse corneal fibroblasts through modulating c-Fos expression.  Conclusion: Our findings reveal that RvD1 conferred protective effects against LPS-induced inflammation by enhancing M2 macrophage polarization through the promotion of c-Fos expression. Thus, RvD1 may be a potential therapeutic compound for enhancing corneal fibroblast proliferation and migration while attenuating inflammation.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Corneal inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Macrophage polarization</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Resolvin D1</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>